NCT02327312

Brief Summary

To evaluate the safety and effectiveness of Trabecular Micro-Bypass stents (two stents per study eye) vs. laser trabeculoplasty, in subjects with open angle glaucoma

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
91

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

9 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

December 16, 2014

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 30, 2014

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2019

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 11, 2020

Completed
Last Updated

December 22, 2022

Status Verified

December 1, 2022

Enrollment Period

4.5 years

First QC Date

November 6, 2014

Last Update Submit

December 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • IOP reduction

    up to 24 months

Secondary Outcomes (1)

  • % IOP reduction

    up to 24 months

Study Arms (2)

Surgical

EXPERIMENTAL

Implantation of two Trabecular Meshwork stents into the study eye

Device: Stents

Laser

ACTIVE COMPARATOR

Laser Trabeculoplasty

Procedure: LaserDevice: Laser Trabeculoplasty

Interventions

StentsDEVICE

Two Trabecular meshwork Micro-Bypass stents into the study eye

Surgical
LaserPROCEDURE

Laser Trabeculoplasty

Laser

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Open angle Glaucoma

You may not qualify if:

  • Active corneal inflammation or edema
  • Choroidal detachment, effusion, choroiditis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Unknown Facility

Glendale, Arizona, 85306, United States

Location

Unknown Facility

Fayetteville, Arkansas, 72704, United States

Location

Unknown Facility

Hemet, California, 92545, United States

Location

Unknown Facility

Cape Coral, Florida, 33904, United States

Location

Unknown Facility

Elizabeth City, North Carolina, 27909, United States

Location

Unknown Facility

Memphis, Tennessee, 38120, United States

Location

Unknown Facility

Fort Worth, Texas, 76102, United States

Location

Unknown Facility

San Antonio, Texas, 78229, United States

Location

Unknown Facility

Racine, Wisconsin, 53405, United States

Location

Related Publications (1)

  • Rolim-de-Moura CR, Paranhos A Jr, Loutfi M, Burton D, Wormald R, Evans JR. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD003919. doi: 10.1002/14651858.CD003919.pub3.

MeSH Terms

Conditions

Glaucoma, Open-Angle

Interventions

StentsLasers

Condition Hierarchy (Ancestors)

GlaucomaOcular HypertensionEye Diseases

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and SuppliesOptical DevicesRadiation Equipment and Supplies

Study Officials

  • Kerry Stephens, OD

    Glaukos Corporation

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 6, 2014

First Posted

December 30, 2014

Study Start

December 16, 2014

Primary Completion

May 31, 2019

Study Completion

August 11, 2020

Last Updated

December 22, 2022

Record last verified: 2022-12

Locations